NCT04118920View on ClinicalTrials.gov

Safety of Topical Insulin Drops for Open-angle Glaucoma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 27, 2023

Primary Completion Date

August 20, 2024

Study Completion Date

December 31, 2024

Conditions
Glaucoma
Interventions
DRUG

Topical insulin (4 units)

N=6: 100 U/ml; 4 units of insulin per application; 40 microliters per drop

DRUG

Topical insulin (20 units)

N=6: 500 U/ml; 20 units of insulin per application; 40 microliters per drop

DRUG

Artificial tears

N=3, 40 microliters per drop

Trial Locations (1)

H2X 3E4

Centre Hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER